🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

12 recruiting trials

for Homozygous Familial Hypercholesterolemia (HoFH)

Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH) NCT07447648n/a13 sites📍 Paris📍 Caserta📍 Catania Fondazione SISA (Societa Italiana per lo Studio della Arter… The ORIGIN-FH Study NCT07470723NA1 site📍 Madison University of Wisconsin, Madison · Tests: Screening for FH Phase II Clinical Trial to Evaluate the Efficacy and Safety of SYH2070 Injection in Participants With Homozygous Familial Hypercholesterolemia NCT07591298Phase 21 site📍 Changsha CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Tests: SYH2070 injection dose1, SYH2070 injection dose2 A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias NCT07491172Phase 117 sites📍 Hialeah📍 Jacksonville📍 Orlando CRISPR Therapeutics AG · Tests: CTX310 Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies NCT05682378Phase 352 sites📍 Boca Raton📍 New York📍 Cincinnati Novartis Pharmaceuticals · Tests: Inclisiran A Dose-exploration Study of EDP167 in HoFH NCT07489209Phase 21 site📍 Beijing Eddingpharm (Zhuhai) Co., Ltd. · Tests: EDP167 Early Detection of Familial Hypercholesterolemia in Children NCT04370899n/a2 sites📍 Reus📍 Reus Institut Investigacio Sanitaria Pere Virgili · Tests: lifestyle assessment Study of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia NCT07473843Phase 33 sites📍 St Louis📍 Viborg📍 Warsaw Arrowhead Pharmaceuticals · Tests: Zodasiran Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia NCT06597006Phase 319 sites📍 San Francisco📍 Washington D.C.📍 St Louis Novartis Pharmaceuticals · Tests: Inclisiran, Placebo The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository NCT01109368n/a1 site📍 New York The Rogosin Institute HoFH, the International Clinical Collaborators Registry NCT04815005n/a4 sites📍 Philadelphia📍 Amsterdam📍 Cape Town University of Pennsylvania · Tests: Demographics, diagnosis type, genotype, lipid profile, treatment allocation, country of residence. NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia NCT06125847EARLY Phase 11 site📍 Xi'an First Affiliated Hospital Xi'an Jiaotong University · Tests: NGGT006
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy